​

Funding Round

Series B - Visen Pharmaceuticals

Series B - Visen Pharmaceuticals

Investment Firm

Overview

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

Announced Date

Jan 08, 2021

Closed on Date

Jan 04, 2021

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorAscendis Pharma
Participant InvestorHBM Healthcare Investments
Participant InvestorOrbiMed
Participant InvestorSofinnova Investments
Participant InvestorVivo Capital

Round Details and Background

Visen Pharmaceuticals raised $150000000 on 2021-01-08 in Series B

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2021
Series B - Visen Pharmaceuticals
11-150.0M
Nov 13, 2018
Series A - Visen Pharmaceuticals
3-40.0M

Recent Activity

There is no recent news or activity for this profile.